Podcast 24: The Pipeline Contenders: What Drugs Are Making the Mark?

In this podcast we feature an article that looks at some key upcoming developments from the pipelines of the large pharmaceutical companies for new drugs or existing drugs with new indications with blockbuster potential.

Key topics: (see Chapter Markers)

  • Inside Big Pharma’s pipeline
  • AbbVie
  • Amgen/AstraZeneca
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Roche

Sponsor: Vetter Pharma International GmbH

Leave a Reply

Your email address will not be published. Required fields are marked *